BioSpace News Archive

Inari Medical, Inc., a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, announced that its management team will present at the 2021 Bank of America Healthcare Conference on Thursday, May 13, 2021 at 8:45 a.m. Eastern Time.

Corvus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, provided a business update and reported financial results for the first quarter ended March 31, 2021.

AmMax Bio, Inc., a private clinical-stage biopharmaceutical company focused on developing novel treatments with AMB-05X, its proprietary anti-CSF1R monoclonal antibody platform, announced that it will present at the BofA Securities 2021 Virtual Healthcare Conference.

Both vonoprazan-based treatment regimens demonstrated superior eradication rates vs. a standard of care proton pump inhibitor (PPI)-based triple therapy

Pacific Biosciences of California, Inc. announced financial results for the quarter ended March 31, 2021.

Evolus, Inc., a performance beauty company with a customer-centric approach focused on delivering breakthrough products, announced that members of management will be participating in the 7th Annual Truist Securities Life Sciences Summit.

LeMaitre, a provider of vascular devices, implants and services, reported Q1 2021 results and announced an $0.11/share quarterly dividend.

Emergent BioSolutions Inc. reported financial results for the quarter ended March 31, 2021.

Halozyme Therapeutics, Inc. announced that Dr. Helen Torley, president and chief executive officer, will present virtually at the BofA Securities 2021 Virtual Health Care Conference on Tuesday, May 11, 2021 at 12:30 p.m. Eastern Time / 9:30 a.m. Pacific Time.

Marker Therapeutics, Inc., a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, announced that it will host a conference call and webcast on Wednesday, May 12, 2021 at 5:00 p.m. Eastern Time to review its first quarter 2021 financial and operating results and provide a corporate update.